In-line monitoring of solid-state transitions during fluidisation

Chemical Engineering Science

Volumn 62, Issue 1-2, 2007, Pages 408-415

  Aaltonen, Jaakko ^a   Kogermann, Karin ^a,b   Strachan, Clare J ^a   Rantanen, Jukka ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Drying; Fluidisation; Multivariate data analysis; Pharmaceuticals; Process control; Solid state transitions

Indexed keywords

DATA REDUCTION; DEHYDRATION; DRUG PRODUCTS; DRYING; FLUIDIZATION; PROCESS CONTROL;

MULTIVARIATE DATA ANALYSIS; PARTIAL LEAST SQUARES REGRESSION; SOLID STATE TRANSITIONS;

PHASE TRANSITIONS;

DATA REDUCTION; DEHYDRATION; DRUG PRODUCTS; DRYING; FLUIDIZATION; PHASE TRANSITIONS; PROCESS CONTROL;

EID: 33750971431     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2006.08.061     Document Type: Article

References (34)

1. Aaltonen J., Rantanen J., Siiriä S., Karjalainen M., Jørgensen A., Laitinen N., Savolainen M., Seitavuopio P., Louhi-Kultanen M., and Yliruusi J. Polymorph screening using near-infrared spectroscopy. Analytical Chemistry 75 (2003) 5267-5273
2. Airaksinen S., Karjalainen M., Räsänen E., Rantanen J., and Yliruusi J. Comparison of the effects of two drying methods on polymorphism of theophylline. International Journal of Pharmaceutics 276 (2004) 129-141
3. Allen F.H. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallographica B 58 (2002) 380-388
4. Barnes R.J., Dhanoa M.S., and Lister S.I. Standard normal variate transformation and de-trending of near-infrared diffuse reflectance spectra. Applied Spectroscopy 43 (1989) 772-777
5. Beebe, K.R., Pell, R.J., Seasholtz, M.B., 1998. Chemometrics: A Practical Guide. Wiley, New York, NY, p. 348.
6. Bernstein J. Polymorphism in Molecular Crystals (2002), Oxford University Press, Oxford
7. Byrn, S.R., Pfeiffer, R.P., Stowell, J.G., 1999. Solid-State Chemistry of Drugs, second ed. SSCI, Inc., West Lafayette, IN, p. 259.
8. Chemburkar S.R., Bauer J., Deming K., Spiwek H., Patel K., Morris J., Henry R., Spanton S., Dziki W., Porter W., Quick J., Bauer P., Donaubauer J., Narayanan B.A., Soldani M., Riley D., and McFarland K. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development. Organic Process Research & Development 4 (2000) 413-417
9. Deeley C.M., Spragg R.A., and Threlfall T.L. A comparison of Fourier transform infrared and near-infrared Fourier transform Raman spectroscopy for quantitative measurements: an application in polymorphism. Spectrochimica Acta A47 (1991) 1217-1223
10. Ebisuzaki Y., Boyle P.D., and Smith J.A. Methylxanthines. I. Anhydrous theophylline. Acta Crystallographica C53 (1997) 777-779
11. Eriksson, L., Johansson, E., Kettaneh-Wold, N., Wold, S., 2001. Multi- and Megavariate Data Analysis: Principles and Applications. Umetrics AB, UmeÅ, Sweden.
12. Geladi P., MacDougall D., and Martens H. Linearization and scatter-correction for near-infrared reflectance spectra of meat. Applied Spectroscopy 39 3 (1985) 481-500
13. Grant D.J.W. Theory and origin of polymorphism. In: Brittain H.G. (Ed). Polymorphism in Pharmaceutical Solids (1999), Marcel Dekker, Inc., New York, NY 1-33
14. Haleblian J., and McCrone W. Pharmaceutical applications of polymorphism. Journal of Pharmaceutical Sciences 58 (1969) 911-929
15. Herman J., Remon J.P., Visavarungroj N., Schwartz J.B., and Klinger G.H. Formation of theophylline monohydrate during the pelletization of microcrystalline cellulose-anhydrous theophylline blends. International Journal of Pharmaceutics 42 (1988) 15-18
16. ICH Q8A Draft Guideline, 2004. Pharmaceutical Development. EMEA/CHMP/167068/2004.
17. Jørgensen A., Rantanen J., Karjalainen M., Khriachtchev L., Räsänen E., and Yliruusi J. Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis. Pharmaceutical Research 19 (2002) 1285-1291
18. Kahela P., Aaltonen R., Lewing E., Anttila M., and Kristoffersson E. Pharmacokinetics and dissolution of two crystalline forms of carbamazepine. International Journal of Pharmaceutics 14 (1983) 103-112
19. Meyer M.C., Straughn A.B., Jarvi E.J., Wood G.C., Pelsor F.R., and Shah V.P. The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharmaceutical Research 9 (1992) 1612-1616
20. Morris K.R. Structural aspects of hydrates and solvates. In: Brittain H.G. (Ed). Polymorphism in Pharmaceutical Solids (1999), Marcel Dekker, Inc., New York, NY 125-181
21. Morris K.R., Griesser U.J., Eckhardt C.J., and Stowell J.G. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing process. Advanced Drug Delivery Reviews 48 (2001) 91-114
22. Nichols G., and Frampton C.S. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. Journal of Pharmaceutical Sciences 87 (1998) 684-693
23. Osborne B.G., Fearn T., and Hindle P.H. Practical NIR Spectroscopy with Applications in Food and Beverage Industry Analysis. second ed (1993), Longman, Harlow, UK
24. Patel A.D., Luner P.E., and Kemper M.S. Quantitative analysis of polymorphs in binary and multi-component powder mixtures by near-infrared reflectance spectroscopy. International Journal of Pharmaceutics 206 (2000) 63-74
25. Phadnis N.V., and Suryanarayanan R. Polymorphism in anhydrous theophylline-implications on the dissolution rate of theophylline tablets. Journal of Pharmaceutical Sciences 86 (1997) 1256-1263
26. Rantanen J., Wikström H., Rhea F.E., and Taylor L.S. Improved understanding of factors contributing to quantification of anhydrate/hydrate powder mixtures. Applied Spectroscopy 59 (2005) 942-951
27. Räsänen E., Rantanen J., Mannermaa J.-P., Yliruusi J., and Vuorela H. Dehydration studies using a novel multichamber microscale fluid bed dryer with in-line near-infrared measurement. Journal of Pharmaceutical Sciences 92 (2003) 2074-2081
28. Räsänen E., Rantanen J., Mannermaa J.-P., and Yliruusi J. The characterization of fluidization behavior using a novel multichamber microscale fluid bed. Journal of Pharmaceutical Sciences 93 (2004) 780-791
29. Savitzky A., and Golay M.J.E. Smoothing and differentiation of data by simplified least squares procedures. Analytical Chemistry 36 (1964) 1627-1639
30. Sun C., Zhou D., Grant D.J.W., and Young V.G. Theophylline monohydrate. Acta Crystallographica E58 (2002) o368-o370
31. Taylor L.S., and Zografi G. The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharmaceutical Research 15 (1998) 755-761
32. U.S. Food and Drug Administration (FDA), (2004a). PAT-A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. U.S. Food and Drug Administration, Rockville, MD.
33. U.S. Food and Drug Administration (FDA), (2004b). Pharmaceutical cGMPs for the 21st Century-A Risk-Based Approach. U.S. Food and Drug Administration, Rockville, MD.
34. Wold S., Sjöström M., and Eriksson L. PLS-regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems 58 (2001) 109-130